Protein News and Research

RSS

Proteins are complex molecules that are made up of amino acids. They can be found in every cell in the body, and carry out vital processes that keep human beings alive. Mutations in proteins can lead to a multitude of diseases, the most common being cancer.

Fluorescent probe can track how tumors respond to drugs

Researchers say the fluorescent probe can track how tumours are responding to the drugs, which harness the body’s immune system to fight disease.

10 May 2022

Tumors release lactate to force neighboring cells into supporting cancer growth

Tumors can force neighboring cells into supporting cancer growth by releasing lactate into their local environment, according to researchers at Weill Cornell Medicine.

10 May 2022

UCLouvain discovery could counter SARS-CoV-2 virus independently of the mutations

Despite the effectiveness of vaccination campaigns worldwide, the threat posed by Covid-19 still exists. First of all, a new SARS-CoV-2 variant could very well emerge that may not respond to current vaccines.

10 May 2022

Using virtual reality headsets to instruct UTSA students about protein structures

Francis Yoshimoto, assistant professor in the UTSA College of Sciences' Department of Chemistry, is introducing his Biochemistry II laboratory students to a new way of learning - using virtual reality headsets to observe and analyze protein structures.

10 May 2022

Postnatal gene therapy may be able to prevent or reverse deadly effects of Pitt-Hopkins syndrome

UNC School of Medicine Scientists have shown for the first time that postnatal gene therapy may be able to prevent or reverse many deleterious effects of a rare genetic disorder called Pitt-Hopkins syndrome.

10 May 2022

Study uncovers new regulator of prostate cancer metastasis

A transcription factor normally associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis, according to a Northwestern Medicine study published in Nature Genetics.

10 May 2022

Evasion of COVID-19 vaccine-medicated mucosal immunity by SARS-CoV-2 Omicron

Researchers depicted the evasion of the SARS-CoV-2 Omicron variant to mucosal immunity in SARS-CoV-2 vaccine recipients.

10 May 2022

Simulating molecular dynamics of SARS-CoV-2 spike variants in the locked conformation

Researchers retrieved the first-ever sequenced spike (S) protein structures of the original Wuhan-Hu 1 SARS-CoV-2 strain, the Alpha, Delta, Delta-plus variants, and Omicron sub-variants BA.1 and BA.2 and compared their structural and molecular level variations.

10 May 2022

Investigating the role of cyclins and cyclin-dependent kinases in host restriction of SARS-CoV-2 infection

Researchers investigated COVID-19-triggered changes in the levels of cyclins and cyclin-dependent kinases inside host cells.

10 May 2022

Heightened antibody responses in COVID-19 booster vaccinated individuals following SARS-CoV-2 Omicron

Investigators illustrated that a SARS-CoV-2 Omicron infection post-booster vaccination imparts robust, long-lasting immunity against future re-infections.

10 May 2022

Sphere Fluidics strengthens commercial team with three new senior hires

Key appointments form part of broader ongoing recruitment plans to support expanded operations and product development.

From Fluidic Sciences and Sphere Bio 10 May 2022

Researchers report widespread prevalence of reactive and acute inflammatory CNS microvasculopathy in 36 COVID-19 brain autopsies

A new study has focused on the microcirculatory factors associated with neurological complications of COVID-19.

10 May 2022

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

A new paper published in Signal Transduction and Targeted Therapy reports the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2.

10 May 2022

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

A study recently published in the journal Cell Host & Microbe has described that all three sublineages of the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit similar host cell entry efficiency and are neutralized equally by antibodies generated in response to coronavirus disease 2019 (COVID-19) booster vaccination

10 May 2022

Protein News and Research

Further Reading

Fluorescent probe can track how tumors respond to drugs

Tumors release lactate to force neighboring cells into supporting cancer growth

UCLouvain discovery could counter SARS-CoV-2 virus independently of the mutations

Using virtual reality headsets to instruct UTSA students about protein structures

Postnatal gene therapy may be able to prevent or reverse deadly effects of Pitt-Hopkins syndrome

Study uncovers new regulator of prostate cancer metastasis

Evasion of COVID-19 vaccine-medicated mucosal immunity by SARS-CoV-2 Omicron

Simulating molecular dynamics of SARS-CoV-2 spike variants in the locked conformation

Investigating the role of cyclins and cyclin-dependent kinases in host restriction of SARS-CoV-2 infection

Heightened antibody responses in COVID-19 booster vaccinated individuals following SARS-CoV-2 Omicron

Sphere Fluidics strengthens commercial team with three new senior hires

Researchers report widespread prevalence of reactive and acute inflammatory CNS microvasculopathy in 36 COVID-19 brain autopsies

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

Novel drug target may help overcome resistance to EZH2 inhibitors in SMARCB1 mutated cancers

Celebrating contributions to Alzheimer’s research and clinical care

Study identifies interleukin-6 as a potential target in refining cancer therapies

Exploring low serum volume assays for SARS-CoV-2 antibodies

Researchers make breakthrough in overcoming drug resistance in a rare, devastating blood cancer

Third BNT162b2 dose elicits more durable immune response than second dose

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo